Research News and Research

RSS

Endo terminates collaboration and axomadol development program with Grunenthal

Endo Pharmaceuticals announced today that it is terminating its research program and collaboration related to the development of axomadol.

18 Aug 2011

Viewpoints: Perry's Texas 'miracle' or 'sad fact'?; Reich on Medicare for all; Orszag on health IT boom

Twenty-six percent of Texans have no health insurance — the highest percentage of medically uninsured residents of any state. It leads the nation in the percentage of children who lack medical insurance. Texas has an inordinate number of employers who provide no insurance to their workers, partly because insurance rates are high, thanks to an absence of regulations.

18 Aug 2011

Ultrasound can predict high risk of stroke in patients with asymptomatic carotid stenosis

A new study shows that a simple ultrasound test may help to identify people at high risk of stroke who have a condition called asymptomatic carotid stenosis, a narrowing of the carotid artery found in the neck, in which few or no symptoms are present.

18 Aug 2011

CEL-SCI receives Chinese patent for Multikine cancer drug

CEL-SCI Corporation today announced that the Chinese patent office has issued a key patent covering CEL-SCI's investigational cancer drug, Multikine.

18 Aug 2011

New research: Sniffer dogs can reliably identify lung cancer

Sniffer dogs could be used for the early detection of lung cancer, according to new research published in the European Respiratory Journal.

18 Aug 2011

Roundup: Rx discounts for Medicaid programs are increasing; deadline extended for Mich. Medigap verifications

Governors have complained repeatedly in recent months that spiraling Medicaid costs are crushing their budgets. But there's good news on at least one line item in the $370 billion program — prescription drug discounts are getting more generous. According to a new report from the Inspector General of the U.S. Health and Human Services Department, discounts under the federal-state Medicaid program have been growing since 2006, adding up to a 45 percent rebate for most brand name drugs by 2009.

18 Aug 2011

Radioiodine being overused in thyroid cancer: Study

According to the latest research the use of radioactive iodine to treat thyroid cancer increased 40 percent from 1990 to 2008 even though the risks may outweigh the benefits for some patients, particularly those with early-stage tumors.

17 Aug 2011

New gout drug may help severely affected: Study

A new drug for gout could help very sick gout patients who don't get better with usual treatment, according to a new study. The research was designed and funded by the pharmaceutical company Savient, which markets the drug, called Krystexxa (pegloticase).

17 Aug 2011

Autism risk in siblings of autistic children is higher: Study

A new study reveals that parents with an autistic child have a 19% increased chance of getting another one with a similar disorder. Experts said the study, published Monday in the journal Pediatrics, is the most comprehensive of its kind and should be used to counsel families.

17 Aug 2011

Inherited genetic links to prostate cancer discovered

Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.

17 Aug 2011

Harmless bacteria re-engineered to fight a deadly strain

Scientists in Singapore have re-engineered a harmless strain of bacteria to fight another common, drug-resistant microbe that spreads in hospitals and is deadly to patients with weak immune systems.

17 Aug 2011

Just 15 minutes of exercise per day prolongs life

Taiwanese researchers reported Monday in the journal The Lancet that exercising for just 15 minutes most days of the week appears to provide health benefits by prolonging life.

17 Aug 2011

Zelboraf receives FDA approval for treatment of metastatic melanoma

The U.S. Food and Drug Administration today approved Zelboraf (vemurafenib), a drug to treat patients with late-stage (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous type of skin cancer.

17 Aug 2011

First Edition: August 17, 2011

In today's headlines, a report about how the timing of the Supreme Court's health law review is in play -- will it happen before or after the 2012 election?

17 Aug 2011

Emergent commences TRU-016 Phase 1b/2 combination trial in relapsed indolent NHL

Emergent BioSolutions Inc. today announced the initiation of a Phase 1b/2 study (16011) of TRU-016 in combination with rituximab and bendamustine for patients with relapsed indolent non-Hodgkin's B-cell lymphomas, including follicular lymphoma, small lymphocytic lymphoma and marginal zone lymphoma.

17 Aug 2011

FDA, USP co-sponsors OTC drug products workshop

Updated public standards incorporating new tests for impurities as well as more modern technologies to help ensure the quality of over-the-counter (OTC) ingredients and products will be key areas of focus for a September 8-9, 2011, workshop co-sponsored by the U.S. Food & Drug Administration (FDA) and the U.S. Pharmacopeial Convention.

17 Aug 2011

Researchers document how immune system can counteract advancement of Alzheimer's

For the first time a research team at Charité - Universitätsmedizin Berlin and Universitätsklinik Freiburg succeeded in documenting how the immune system can counteract the advancement of Alzheimer's disease.

17 Aug 2011

The Washington Post explores comparative effectiveness research

American medical care is rife with such treatments, whose usefulness is uncertain not just to the doctors who deliver them but also to the patients who receive them. These days, however, many people are pinning their hopes on "comparative effectiveness research" as way to solve the dilemma of how best to treat this and hundreds of other common problems in day-to-day medicine.

17 Aug 2011

Clinical trial to assess 6MP drug in women with advanced breast or ovarian cancer

A CANCER RESEARCH UK-funded trial of a new drug for patients with advanced breast or ovarian cancer due to inherited gene faults has been launched at the Oxford Experimental Cancer Medicine Centre (ECMC) at the University of Oxford.

17 Aug 2011

Debate emerges regarding benefit of CT scans for lung cancer

Some hospitals are offering discounted CT scans to worried smokers, leading experts to question whether it's a marketing strategy or offers some health benefit.

17 Aug 2011